Infosys (INFY) Q2 2027 Earnings Call Transcript

Infosys reported Q2 FY2027 revenue of $5.145 billion, up 1.5% year over year in constant currency, below management expectations, and cut full-year revenue growth guidance to 1%-2%; operating-margin guidance remains 20%-22%. AI revenue represented 10.5% of revenue and grew 29% sequentially, while large deal wins totaled $5.2 billion, 62% net new, including a net-new, seven-year deal worth more than $2 billion that management expects to contribute over 1% to FY2028 revenue growth. Operating margin was 21% and free cash flow was $928 million; management cited cautious client spending, softer volumes, and competitive pricing pressure, while the board announced an interim dividend of INR 26 per share, up 13% year over year.

Analysis

INFY’s key tension is not whether AI demand exists, but whether it replaces labor-based revenue faster than new AI work can scale. Productivity commitments can lift client value while reducing billable effort and resetting renewal prices; the company’s reported AI growth is therefore not yet proof of positive net growth across the installed base. The moat is execution and integration, but competitors can bid away economics as AI becomes table stakes.

Near term (days to weeks), the lower growth outlook and softer pricing matter more than multiyear contract value for earnings sensitivity. Over 1–3 months, watch whether seasonal softness and compensation increases pressure margins despite cost actions. Deal wins are a leading indicator, not booked revenue: the large financial-services award’s material contribution is framed for FY2028, so it offers limited protection against near-term conversion and legacy-book leakage. Over 6–18 months, the bull case is that AI-led new work and deal ramp exceed productivity-related price/volume erosion; the bear case is revenue substitution with inadequate incremental economics.

The headline AI growth rate risks being overinterpreted: verify the company’s definition, whether revenue is genuinely incremental versus reclassified or migrated work, and its renewal economics. ACN is a plausible relative-value hedge, but this transcript alone does not establish a valuation- or fundamentals-adjusted pair. Falsify the cautious view if INFY delivers sustained organic growth improvement alongside stable pricing and margins; worsening guidance or continued price pressure would reinforce it.

Key Decisions for Investors

• Keep INFY underweight/avoid adding on AI-growth headlines; the near-term risk/reward is constrained by pricing pressure, soft volumes, and compensation costs. Reassess after the next results rather than treating TCV as near-term revenue.
• Set a 1–3 month alert on constant-currency growth, renewal pricing, and operating margin: a growth recovery without margin deterioration would challenge the cautious thesis; further guidance cuts or margin slippage would support it.
• Treat an INFY-versus-ACN pair as a watchlist idea, not a current recommendation. Before initiating, compare relative valuation, organic growth, and AI revenue definitions; the article provides no comparable ACN figures.
• Over 6–18 months, monitor conversion and ramp timing of net-new deals against legacy contract productivity concessions. If AI work demonstrably offsets book erosion while preserving economics, revisit the underweight.